Stock A278650 HLB BIOSTEP CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News HLB bioStep Co.,Ltd.

Equities

A278650

KR7278650007

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-08 pm EDT 		5-day change 1st Jan Change
3,575 KRW +1.13% Intraday chart for HLB bioStep Co.,Ltd. -4.16% +15.70%
Apr. 25 HLB bioStep Co.,Ltd. announced that it expects to receive KRW 1.438165744 billion in funding from Kangstem Biotech Co., Ltd. CI
Mar. 08 Tranche Update on HLB bioStep Co.,Ltd.'s Equity Buyback Plan announced on December 4, 2023. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HLB bioStep Co.,Ltd. announced that it expects to receive KRW 1.438165744 billion in funding from Kangstem Biotech Co., Ltd.
CI
Tranche Update on HLB bioStep Co.,Ltd.'s Equity Buyback Plan announced on December 4, 2023.
CI
HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares.
CI
HLB bioStep Co.,Ltd. authorizes a Buyback Plan.
CI
HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.
CI
HLB bioStep Co.,Ltd. authorizes a Buyback Plan.
CI
Panagene Inc. announced that it expects to receive KRW 56.599994061 billion in funding from a group of investors
CI
Panagene Inc. announced that it expects to receive KRW 46.068324061 billion in funding from HLB Co., Ltd., HLB Investment Co., Ltd., HLB bioStep Co.,Ltd., HLB innoVation Co.,Ltd., HLB Therapeutics Co.,Ltd.
CI
HLB innoVation Co.,Ltd. announced that it has received KRW 55.99999522 billion in funding from a group of investors
CI
HLB SCIENCE Inc. announced that it has received KRW 5.0000004 billion in funding from HLB bioStep Co.,Ltd.
CI
HLB SCIENCE Inc. announced that it expects to receive KRW 5.0000004 billion in funding from HLB bioStep Co.,Ltd.
CI
HLB innoVation Co.,Ltd. announced that it expects to receive KRW 55.99999522 billion in funding from a group of investors
CI
KNOTUS Co.,Ltd's Equity Buyback announced on March 13, 2020 has expired with 71,714 shares, representing 0.98% for KRW 960.15 million.
CI
KNOTUS Co.,Ltd announced that it has received KRW 81.1 billion in funding
CI
HLB Co., Ltd. entered into a contract to acquire 18.4% stake in KNOTUS Co.,Ltd from Jeong In-seong and Kim Do-hyung for KRW 56.2 billion.
CI
KNOTUS Co.,Ltd announced that it expects to receive KRW 94.6 billion in funding
CI
KNOTUS Co.,Ltd(KOSDAQ:A278650) added to S&P Global BMI Index
CI
Tranche Update on KNOTUS Co.,Ltd's Equity Buyback Plan announced on March 13, 2020.
CI
Tranche Update on KNOTUS Co.,Ltd's Equity Buyback Plan announced on March 13, 2020.
CI
KNOTUS Co.,Ltd's Equity Buyback Plan Extended till March 12, 2022.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A278650 Stock
  4. News HLB bioStep Co.,Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW